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1099-91 Treatment and Outcome of Diabetic Patients With Stable 
Angina and First Angiographic Diagnosis of Coronary 
Artery Disease in Germany: Results of the STAR 
Registry
Anselm K. Gitt, Harm Wienbergen, Christina Vogel, Tobias Heer, Karl Siegler, Martin G. 
Gottwik, Jochen Senges, The STAR Study Group, Herzzentrum Ludwigshafen, 
Ludwigshafen, Germany, Klinikum Nuernberg Sued, Nuernberg, Germany
Background: In diabetics coronary artery disease (CAD) contributes considerably to
mortality in Germany. Little information exist on the extent of CAD in diabetic patients
(pts) with stable angina pectoris (AP) as well as their treatment and outcome in clinical
practice.
Methods: Between September 2001 and March 2003, consecutive pts with stable AP
and first angiographic diagnosis of CAD were enrolled into the STAR-Registry in 53 hos-
pitals. We examined the differences between pts with and without diabetes as well as the
impact of diabetes on treatment and outcome.
Results: Diabetics with stable angina and first angiographic diagnosis of CAD were older
and more often had concomitant diseases than non-diabetics. Three-vessel disease was
more prevalent in diabetics than in non-diabetics. Diabetics did undergo PCI significantly
less often. According to the higher prevalence of multivessel disease, diabetics under-
went CABG more often during the 1-year follow-up. Diabetics received the combination
of ASS, statins, betablockers and ACE-inhibitors as well as symptomatic treatment with
nitrates more often than non-diabetics. 
Conclusion: Diabetics with stable angina and first angiographic diagnosis of CAD more 
often presented with multivessel disease. Diabetics did undergo PCI for stable angina 
significantly less often than non-diabetics, but were more often treated by CABG during 
1-year follow-up. Mortality in diabetics after one year of follow-up was 3 times higher than 
in non-diabetics.
1099-92 Coronary Artery Aneurysms Are an Independent 
Predictor of High Five-Year Mortality
Timir Baman, Jason H. Cole, Chandan Devireddy, Laurence S. Sperling, Emory 
University, Atlanta, GA
Background: Coronary aneurysms may be incidentally seen on cardiac catheterization.
However, outcomes in patients with aneurysms have not been well defined because of
the small size and limited follow-up in published series. Methods: Patients with coronary
aneurysmal disease, defined as dilatation >2.0 times the diameter of adjacent normal
segments, were identified from all patients who underwent diagnostic coronary angiogra-
phy at Emory University Hospitals between 1995 and 2002. Cath films were then
reviewed, and aneurysm size and location were confirmed. Coexisting cardiac risk fac-
tors and follow-up mortality data were obtained on all patients. Controls presenting dur-
ing the same period were selected by 2:1 frequency matching on the basis of obstructive
CAD (>70% stenosis in one or more vessels). Kaplan-Meier survival curves were plotted
for aneurysm patients with and without obstructive CAD, and compared with the log-rank
test. A Cox proportional hazards model was developed to evaluate correlates of mortality.
Results: 276 patients were identified; 186 (70.5%) were also found to have obstructive
CAD. Compared with controls, aneurysm patients were less likely to be diabetic (18.1%
vs. 26.1%, p=0.01) or current smokers (12.7% vs. 18.7%, p=0.03), but were more likely
to be male (82.9% vs. 60.4%, p<0.001) or hyperlipidemic (55.3% vs. 43.8%, p=0.002).
Frequency of hypertension did not differ significantly between groups. No association
was found between aneurysm size and survival or any cardiac risk factor. Unadjusted 5-
year survival was 71.2%, with no significant difference for aneurysm patients with and
without obstructive CAD (71.9% vs. 67.9%, p=0.77). In the Cox model, aneurysm was a
significant predictor of mortality (HR 1.62, 95% CI 1.29 to 2.02), as were diabetes (HR
1.83), obstructive CAD (HR 1.71), and hyperlipidemia (HR 1.73). Conclusions: In an
unselected adult population, coronary aneurysms are variably associated with traditional
cardiac risk factors and are an independent predictor of significant 5-year mortality. Clini-
cians should work to aggressively modify coronary risk factors in aneurysm patients with
and without coexisting obstructive CAD.
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826-2 Interleukin-6 but Not C-Reactive Protein Is Elevated at 
the Site of Ruptured Plaques in Acute Coronary 
Syndromes
Lukas A. Altwegg, Roberto Corti, Arnold von Eckardstein, Friedrich Maly, Gabor Sütsch, 
Marco Roffi, Franz R. Eberli, Lukas Bestmann, Bernd van der Loo, Thomas F. Lüscher, 
Willibald Maier, University Hospital Zürich, Zürich, Switzerland
Background: Plaque rupture in acute coronary syndromes (ACS) has been shown to be
associated with an increased inflammatory activity. However, it remains unclear to what
extent markers of inflammation originate from the site of the plaque rupture or represent
a systemic process. Therefore, we analyzed in patients undergoing acute percutaneous
coronary interventions (PCI) blood from the aorta and from the site of the ruptured coro-
nary plaque under exclusion from the systemic circulation.
Methods: In 41 patients with ACS a balloon-based protection device (PersuSurge™) was
used to provide protection of the microcirculation from distal embolization. Samples from
the site of the ruptured plaque were taken using an aspiration catheter under distal bal-
loon occlusion after the first successful crossing of the lesion in 17 left coronary, 2 cir-
cumflex and 22 right coronary arteries. Solid material (thrombus and plaque particles)
was separated by means of a filter. The remaining blood was analyzed for CRP and IL-6
and compared with samples simultaneously taken from the aorta. Measurements are
expressed as the ratio between the concentrations in the culprit vessel and the aorta.
Results: Both total CRP (7.0±2.3mg/l) and Il-6 levels (5.5±2.3ng/l) were systemically ele-
vated in this group of patients with ACS. In relation to aortic concentrations, IL-6 levels
were markedly higher (+252%, p=0.001) at the site of the ruptured plaque, whereas CRP
levels were significantly lower ( -12%, p=0.001) compared to the aorta.
Conclusion: Patients with ACS show systemically elevated levels of inflammatory mark-
ers (CRP and IL-6). In the culprit vessel, IL-6 levels are higher in comparison to the aorta,
while CRP-levels are significantly lower. This may reflect either CRP consumption or
uptake in a compartment with local stasis separated from the circulation by the coronary
occlusion and suggests that systemic elevation of CRP is an indicator of a generalized
inflammatory process. In contrast, IL-6 seems to be locally released. These findings
impact on current concepts of the pathogenesis of plaque rupture and myocardial infarc-
tion.
4:30 p.m.
826-3 Early Elevation of C-Terminal Telopeptide of Type I 
Collagen Is Highly Correlated With 30-Day Mortality in 
Patients With Myocardial Infarction Regardless of 
Infarct Localization
Cord A. Manhenke, Stein Ørn, Faiez Zannad, Torbjørn Aarsland, Kenneth Dickstein, The 
OPTIMAAL Trial Study Group, Rogaland Central Hospital, Stavanger, Norway
Background: Prognosis after acute myocardial infarction (AMI) is related to infarct size
and localization. We related increased serum levels of c-terminal telopeptide of type I col-
lagen (ICTP), a marker of type I collagen degradation, to 30 day all-cause mortality and
infarct localization in patients following complicated AMI.
Methods: Serum from 233 patients in the OPTIMAAL trial which included patients follow-
ing AMI, with heart failure and/or left ventricular dysfunction was sampled at randomiza-
tion (mean 3 days after index MI).
Results: Mean ICTP for all patients was 4.9(+2.7) µg/l. Within 30 days after AMI, 14
patients died. Non-survivors had significantly higher ICTP levels than those who survived
(mean 8.6(+5.1) vs. 4.7(+2.2) µg/l, p<.0001). Patients above and below mean ICTP had a
mortality rate of 15% (n=13/84) and 0.7% (n=1/149) respectively (p<.0001) (fig.). There
were no statistically significant differences in ICTP-levels with respect to infarct localiza-
tion.
Conclusion: Increased serum-levels of ICTP are strongly associated with increased
short-term mortality following complicated AMI. ICTP may help to stratify patients with
AMI into high and low risk groups for short-term mortality independent of infarct localiza-
tion.
Diabetics
N=518
Non-Diabetics
N=1435
p-value
Age (years) 69 66 <0.01
Male Gender 64.1 % 72.3 % <0.01
Hypercholesteremia 73.4 % 66.3 % <0.01
Hypertension 83.4 % 70.3 % <0.01
Atrial fibrillation 8.3 % 7.0 % ns
3-Vessel-Disease 30.7 % 24.2 % <0.01
PCI 38.4 % 48.4 % <0.01
Statin+BB+ACE+ASS 42.5 % 35.1 % <0.01
Nitrates 35.3 % 27.9 % <0.01
1-Year-Complications
Death 7.5 % 2.7 % <0.01
Nonfatal MI 2.1 % 2.4 % ns
Nonfatal Stroke 1.9 % 1.4 % ns
Re-PCI 19.4 % 20.5 % ns
CABG 31.1 % 24.9 % <0.01
Hospitalisation for UA 27.8 % 29.3 % ns
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826-4 B-Type Natriuretic Peptide Levels on Admission Predict 
Short-Term Mortality and Angiographic Success of 
Procedure in Patients With Acute ST Elevation 
Myocardial Infarction Treated With Primary Angioplasty
Marcin Grabowski, Krzysztof J. Filipiak, Grzegorz Karpinski, Adam Rdzanek, Arkadiusz 
Pietrasik, Zenon Huczek, Grzegorz Horszczaruk, Janusz Kochman, Grzegorz Opolski, 
Medical University of Warsaw, Warsaw, Poland
Background: B-type natriuretic peptide (BNP) levels in the first days after the onset of
symptoms are predictive of short-term mortality in patients with acute coronary syn-
dromes. Few data are available for BNP levels obtained on admission in patients (pts)
with acute ST elevation myocardial infarction (STEMI). Methods: Blood samples for BNP
determination were obtained on admission in 117 pts (mean age 58,4±10,7 years old)
with STEMI. In a 15-minute period, BNP was measured by using simple bedside test for
rapid quantification of BNP, before primary percutaneus coronary intervention (PCI). 30
days follow-up was performed. PCI was performed in all (100%) pts. Results: Mean for
BNP was 171,8±218,2 pg/ml. Baseline level of BNP was higher among pts who died than
among those who were alive at 30 days (median, 541,9±247,2pg/ml vs. 140,9±185,9 pg/
ml; p<0,001). Baseline BNP in subgroups by median level showed a significant increase
in mortality: 1 (1%) in inframedian group (IMG) vs. 8 (13%) in supramedian group (SMG)
(p<0,05). Baseline level of BNP in subgroups by Killip class on admission was higher
among pts who died than among those who were alive at 30 days (Killip class I: median,
475,8± 280,6 pg/ml vs. 123,6±138,1 pg/ml p<0,05; Killip class II-IV: 257,1± 362,5 pg/ml
vs. 624,5± 203,9 pg/ml, p=0,01). After adjustment for independent predictors of risk of
death, the odds ratio for death at 30 days in SMG was 13,6 (95% confidence interval, 1.1
to 182.7). There was no difference in subgroups by median BNP in TIMI 3 flow grade
before PCI (7% vs. 7%; p=NS). TIMI 3 after PCI was more often seen in pts in IMG vs.
SMG (90% vs. 72%, p=0,01). BNP was higher among pts with TIMI 0, 1 or 2 after PCI
than among pts with TIMI 3 after PCI (328,3±332,8 pg/ml vs. 151,32±196,7 pg/ml;
p<0,01). BNP remained independent predictor for TIMI 0, 1 or 2 after PCI (odds ratio in
SMG was 3,5 (95% confidence interval 1,2 to 10,8). Conclusion: BNP levels obtained on
admission are powerful, independent indicator of short-term mortality and angiographic
success after PCI in pts with STEMI. Rapid tests for BNP assay seem to be new tool in
risk stratification of pts with STEMI.
5:00 p.m.
826-5 Profiling Inflammation in the Ischemic Human Heart In 
Vivo
Anders Gabrielsen, Patrick Lawler, Jesper Haeggström, Gabrielle Berne Paulsson, Wang 
Yongzhong, Daniel Steinbruchel, Jens Kastrup, Goran Hansson, Karolinska Institute, 
Stockholm, Sweden, Copenhagen University Hospital, Copenhagen, Denmark
Background: The present understanding of myocardial inflammation and its potential
role in myocardial pathophysiology is incomplete. Therefore, we used Affymetrix® Gene-
Chip analysis on normal and chronic ischemic myocardium before and during acute
ischemia and reperfusion stress to profile expression of inflammation-related transcripts.
Methods: Biopsies were sampled at baseline, after 45 min of acute total ischemia, and
after 30 min of reperfusion recovery from normally perfused and chronic reversibly
ischemic myocardium in 6 patients undergoing coronary artery by-pass grafting. RNA
was isolated, amplified with established techniques, and hybridized to HG_U133A
Affymetrix® Genechip arrays. A total of 33 arrays were performed, normalized with the
RMA algorithm, and analyzed for expression patterns of pro- and anti-inflammatory fac-
tors.
Results: At baseline, expression of 5-lipoxygenase, MCP-1 and IL-6 was higher in
chronic ischemic myocardium than in normally perfused myocardium. In response to
acute ischemia and reperfusion in the normal myocardium, there was a clear trend
towards increased expression of pro-inflammatory factors (e.g. 5-lipoxygenase, COX-2,
CysLT2 receptor, MCP-1, IL-6). These responses were less pronounced or detectably
absent in the chronic ischemic myocardium.
Conclusion: These findings suggest a discrete increase in several pro-inflammatory fac-
tors that may contribute to myocardial pathophysiology in chronic myocardial ischemia.
The blunted inflammatory response to acute ischemia in the chronic ischemic myocar-
dium may suggest altered sensitivity in signaling pathways mediating the inflammatory
response.
5:15 p.m.
826-6 Hyponatremia: A Useful Marker for Early Risk 
Assessment in Acute ST Elevation Myocardial Infarction
Alexander Goldberg, Haim Hammerman, Sirouch Petcherski, Sergey Yalonetsky, 
Alexander Zdorovyak, Michael Kapeliovich, Walter Markiewicz, Doron Aronson, Rambam 
Medical Center, Haifa, Israel, Rappaport Medical School, Haifa, Israel
Background: Hyponatremia (HNa) is common in hospitalized patients and is associated
with adverse prognosis, especially in heart failure. Data on the prevalence and prognostic
significance of HNa in the setting of acute ST-elevation myocardial infarction (STEMI) is
sparse.
Methods: We studied 1047 consecutive patients (pts) (age 60 ± 12) presenting with
STEMI. Plasma sodium concentrations (PNa) were obtained on admission and at 24-h,
48-h, and 72-h. Multiple logistic regression was performed to determine the relation
between HNa and 30-day mortality adjusting for age, sex, diabetes, hypertension, smok-
ing, Killip class, peak CK, LVEF, anterior infarction, use of diuretics and reperfusion ther-
apy.
Results: HNa (PNa < 135 mmol/L) was present on admission in 131 pts (12.5%) and
developed in 208 (19.9%) during the first 72-h. PNa decreased to <130 mmol/L in 75
(7.2%) of pts. Pts receiving diuretics developed HNa more commonly compared to pts
who were not (46% vs 28%, p< 0.0001), but the majority of hyponatremic pts (66%) were
not receiving diuretics. Kaplan-Meyer curves indicated that pts with HNa were at
increased risk of mortality (Figure). HNa on admission (OR 2.2, 95% CI 1.2-4.2, p=
0.015) and HNa developing early after admission (OR 2.7, 95% CI 1.6-4.6, p< 0.0001)
were independent predictors of 30-days mortality.
Conclusion: HNa on admission, or early development of HNa in patients with STEMI is
a strong independent predictor of 30-day mortality. PNa may serve as a simple marker to
identify patients at high risk. 
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827-2 Fasting Glucose Is an Independent Predictor of 30-Day 
Mortality in Nondiabetic Patients With Acute Myocardial 
Infarction: A Prospective Study
Mahmoud Suleiman, Walter Markiewicz, Michael Kapeliovich, Haim Hammerman, Doron 
Aronson, Rambam Medical Center, Haifa, Israel
Background: Studies have suggested that hyperglycemia may increase mortality after
acute myocardial infarction (AMI). However, these studies have not adjusted for important
determinants of prognosis and hyperglycemia was defined arbitrarily as a dichotomous
